Firm at a glance
Ridgemont Equity Partners is a platform private equity firm founded in 2010 and headquartered in Charlotte, NC, per its own website [S1].
What they buy
The firm’s portfolio reflects a focus on three primary sectors: business and technology services, healthcare, and industrial growth businesses [S2]. Observed investments span technology-enabled services, healthcare providers and services, logistics and transportation, distribution, and specialty manufacturing [S2]. The firm closed its fifth fund at approximately $3.975 billion in September 2025 [S1]. Portfolio activity since 2020 suggests the firm pursues both new platform acquisitions and add-on transactions to existing holdings [S2].
Portfolio
Business & Technology Services
Caring Transitions (acquired 2026), Renovo Solutions (2026), CRS (2025), Unosquare (2025), Strata Information Group (2024), smartShift (2023), WhiteWater III/Matterhorn (2022), Teachers of Tomorrow (2021), Softdocs (2021), WhiteWater III/BANGL (2020), Certus (2020), M6 (2020), and Allredi (2014) [S2].
Healthcare
HealthMark Group (2025), Medicus Healthcare Solutions (2024), American Outcomes Management (2022), Agape Care Group (2021), Sparus Holdings (2021), Anne Arundel Dermatology (2020), and HemaSource (2017) [S2].
Industrial Growth
National Power (2023), Crete United (2022), RoadOne IntermodaLogistics (2022), Worldwide Produce (2022), Northstar Recycling Company (2021), Omni Logistics & Forward Air (2020), Munch’s Supply & Marcone (2019), Fleetpride Corporation (2018), and WWEX Group (2017) [S2].
Recent activity (last 24 months)
* Caring Transitions acquisition, July 16, 2026 [S1]
* Renovo Solutions acquisition, 2026 [S2]
* Fund V closed at approximately $3.975 billion, September 25, 2025 [S1]
* Unosquare acquisition, June 12, 2025 [S1]
* HealthMark Group acquisition, 2025 [S2]
* CRS acquisition, January 7, 2025 [S1]
* Waste Technology Services add-on acquisition, October 14, 2024 [S1]
* Strata Information Group acquisition, 2024 [S2]
* Medicus Healthcare Solutions acquisition, 2024 [S2]
How this firm fits a seller
Ridgemont appears to target middle-market platforms in sectors where it has demonstrated repeat investment activity, particularly business services, healthcare services, and industrial distribution or logistics [S2]. The firm’s recent fund close and continued acquisition pace through 2026 suggest active deployment capacity [S1][S2]. For owner-operators in technology-enabled services, healthcare, or industrial sectors, the firm’s portfolio history indicates experience building platforms through both organic growth and add-on acquisitions [S2]. The Charlotte headquarters may appeal to sellers in the Southeast, though the portfolio includes companies across the United States [S1][S2].
Sources
[S1] https://www.ridgemontep.com (as of 2026-01-15)
[S2] https://www.ridgemontep.com/portfolio/ (as of 2026-01-15)
Frequently asked questions
Does Ridgemont Equity Partners buy healthcare businesses?
Yes, healthcare represents a significant portion of the firm’s portfolio [S2]. Recent healthcare acquisitions include HealthMark Group (2025), Medicus Healthcare Solutions (2024), and American Outcomes Management (2022), alongside earlier investments in dermatology, hospice, and specialty healthcare services [S2].
What companies has Ridgemont Equity Partners acquired recently?
Recent acquisitions include Caring Transitions in July 2026, Renovo Solutions in 2026, and CRS in January 2025 [S1][S2]. The firm also acquired Unosquare in June 2025 and HealthMark Group in 2025 [S1][S2].
Where is Ridgemont Equity Partners based and how big is the firm?
The firm is based in Charlotte, NC [S1]. Ridgemont closed its fifth fund at approximately $3.975 billion in September 2025, per its website [S1].
Is Ridgemont Equity Partners still actively acquiring?
Yes, the firm completed multiple acquisitions in 2026, including Caring Transitions in July and Renovo Solutions earlier in the year, indicating active deal flow [S1][S2].
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.